Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies

The Lancet Respiratory Medicine

Volumn 5, Issue 3, 2017, Pages 200-211

  Darvishian, Maryam ^a,b,c,d   van den Heuvel, Edwin R ^e   Bissielo, Ange ^f   Castilla, Jesus ^g,h   Cohen, Cheryl ^i,j   Englund, Helene ^k   Gefenaite, Giedre ^l   Huang, Wan Ting ^m   la Bastide van Gemert, Sacha ^a   Martinez Baz, Iván ^g,h   McAnerney, Johanna M ⁱ   Ntshoe, Genevie M ⁱ   Suzuki, Motoi ⁿ   Turner, Nikki ^o   Hak, Eelko ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^g INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^j UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^k SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^l LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^m CENTER FOR DISEASE CONTROL   (Taiwan)

ⁿ NAGASAKI UNIVERSITY   (Japan)

^o UNIVERSITY OF AUCKLAND   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; CASE CONTROL STUDY; DRUG EFFICACY; HEALTH STATUS; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; META ANALYSIS; OUTCOME ASSESSMENT; RISK REDUCTION; SEASONAL INFLUENZA; SYSTEMATIC REVIEW; VIRUS STRAIN; AGED; EPIDEMIC; FEMALE; INDEPENDENT LIVING; INFLUENZA; MALE; METHODOLOGY; SEASON; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VACCINATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EPIDEMICS; FEMALE; HUMANS; INDEPENDENT LIVING; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RESEARCH DESIGN; SEASONS; TREATMENT OUTCOME; VACCINATION;

EID: 85012937223     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30043-7     Document Type: Article

References (50)

1. 1 Castilla, J, Martínez-Baz, I, Martínez-Artola, V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill, 18, 2013, 20388.
2. 2 Darvishian, M, Bijlsma, MJ, Hak, E, van den Heuvel, ER, Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis 14 (2014), 1228–1239.
3. 3 Lang, PO, Govind, S, Mitchell, WA, Siegrist, CA, Aspinall, R, Vaccine effectiveness in older individuals: what has been learned from influenza-vaccine experience. Ageing Res Rev 10 (2011), 389–395.
4. 4 Belongia, EA, Simpson, MD, King, JP, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 16 (2016), 942–951.
5. 5 Hak, E, Nordin, J, Wei, F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 35 (2002), 370–377.
6. 6 Macintyre, CR, Heywood, AE, Kovoor, P, et al. Ischaemic cardiovascular disease, influenza and influenza vaccination: a prospective case control study. Cardiovascular 99 (2013), 1843–1848.
7. 7 Remschmidt, C, Wichmann, O, Harder, T, Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med, 13, 2015, 53.
8. 8 De Serres, G, Skowronski, D, Wu, X, Ambrose, C, The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized placebo-controlled clinical trials. Euro Surveill, 18, 2013, 20585.
9. 9 Haber, M, An, Q, Foppa, IM, Shay, DK, Ferdinands, JM, Orenstein, WA, A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies. Epidemiol Infect 143 (2015), 1417–1426.
10. 10 Van Houwelingen, HC, Zwinderman, KH, Stijnen, T, A bivariate approach to meta-analysis. Stat Med 12 (1993), 2273–2284.
11. 11 Van Houwelingen, HC, Arends, LR, Stijnen, T, Tutorial in biostatistics. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21 (2002), 589–624.
12. 12 Hak, E, Verheij, TJ, Grobbee, DE, Nichol, KL, Hoes, AW, Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 56 (2002), 951–955.
13. 13 Tudur Smith, C, Marcucci, M, Nolan, SJ, et al. Individual participant data meta-analyses compared with meta-analyses based on aggregate data. Cochrane Database Syst Rev, 9, 2016, MR000007.
14. 14 European Centre for Disease Prevention and Control. Protocol for case-control studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States. http://ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf (accessed Nov 3, 2015).
15. 15 Weinberg, GA, Szilagyi, PG, Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis 201 (2010), 1607–1610.
16. 16 WHO. WHO recommendations on the composition of influenza virus vaccines. http://www.who.int/influenza/vaccines/virus/recommendations/en/, 2014 (accessed Nov 3, 2015).
17. 17 Kelly, HA, Sullivan, SG, Grant, KA, Fielding, JE, Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011. Influenza Other Respir Viruses 7 (2013), 729–737.
18. 18 Barr, IG, McCauley, J, Cox, N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season. Vaccine 28 (2009), 1156–1167.
19. 19 European Centre for Disease Prevention and Control. Indicators of influenza activity. http://ecdc.europa.eu/en/healthtopics/influenza/surveillance/Pages/indicators_influenza.aspx (accessed Nov 3, 2015).
20. 20 Van den Heuvel, ER, A comparison of estimation methods on the coverage probability of Satterthwaite confidence intervals for assay precision with unbalanced data. Commun Stat Sim Comp 39 (2010), 777–794.
21. 21 Demetrashvili, N, Wit, EC, van den Heuvel, ER, Confidence intervals for intraclass correlation coefficients in variance components models. Stat Methods Med Res 25 (2016), 2359–2376.
22. 22 Higgins, JP, Thompson, SG, Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558.
23. 23 Cooper, H, Hedges, LV, Valentine, JC, The handbook of research synthesis and meta-analysis, 2nd edn., 2009, Russell Sage Foundation, New York.
24. 24 Donders, AR, van der Heijden, GJ, Stijnen, T, Moons, KG, Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59 (2006), 1087–1091.
25. 25 Rubin, DB, An overview of multiple imputation. http://ww2.amstat.org/sections/SRMS/Proceedings/papers/1988_016.pdf (accessed Dec 30, 2015).
26. 26 Castilla, J, Martínez-Artola, V, Salcedo, E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: cohort and case-control study. Vaccine 30 (2012), 195–200.
27. 27 Martínez-Baz, I, Martínez-Artola, V, Reina, G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case-control study. BMC Public Health, 13, 2013, 191.
28. 28 Martínez-Baz, I, Navascués, A, Poxo, F, et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccine Immunoter 11 (2015), 1626–1633.
29. 29 Englund, H, Campe, H, Hautmann, W, Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 141 (2013), 1807–1815.
30. 30 Gefenaite, G, Rahamat-Langendoen, J, Ambrozaitis, A, et al. Seasonal influenza vaccine effectiveness against influenza in 2012–2013: a hospital-based case-control study in Lithuania. Vaccine 32 (2014), 857–863.
31. 31 Kelly, H, Carville, K, Grant, K, Jacoby, P, Tran, T, Barr, I, Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One, 4, 2009, e5079.
32. 32 Sullivan, SG, Kelly, H, Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro Surveill, 18, 2013, 20605.
33. 33 Lo, YC, Chuang, JH, Kuo, HW, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011–12 season. PLoS One, 8, 2013, e58222.
34. 34 McAnerney, JM, Walaza, S, Cohen, AL, et al. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010–2013. Influenza Other Respir Viruses 9 (2015), 143–150.
35. 35 McAnerney, JM, Treurnicht, F, Walaza, S, et al. Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014. Influenza Other Respir Viruses 9 (2015), 209–215.
36. 36 Ntshoe, GM, McAnerney, JM, Tempia, S, et al. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005–2009. PLoS One, 9, 2014, e94681.
37. 37 Suzuki, M, Yoshimine, H, Harada, Y, et al. Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan. PLoS One, 8, 2013, e52103.
38. 38 Suzuki, M, Minh le, N, Yoshimine, H, et al. Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011–2012 season. PLoS One, 9, 2014, e88813.
39. 39 Turner, N, Pierse, N, Bissielo, A, et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalizations in Auckland, New Zealand in 2012. Vaccine 32 (2014), 3687–3693.
40. 40 Turner, N, Pierse, N, Bissielo, A, et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill, 19, 2014, 20884.
41. 41 Turner, N, Pierse, N, Huang, QS, et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalizations and primary care visits in Auckland, New Zealand, in 2014. Euro Surveill, 19, 2014, 20934.
42. 42 Andrews, N, McMenamin, J, Durnall, H, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill 19 (2014), 5–13.
43. 43 Skowronski, DM, Chambers, C, Sabaiduc, S, et al. Integrated sentinel surveillance linking genetic, antigenic and epidemiologic monitoring of influenza vaccine-virus relatedness and effectiveness, 2013–14 season. J Infect Dis 212 (2015), 726–739.
44. 44 Kissling, E, Valenciano, M, Cohen, JM, et al. I-MOVE multi-centre case control study 2010–11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One, 6, 2011, e27622.
45. 45 Kissling, E, Valenciano, M, Larrauri, A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill, 18, 2013, 20390.
46. 46 Kissling, E, Valenciano, M, Buchholz, U, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill, 19, 2014, 20701.
47. 47 McLean, HQ, Thompson, MG, Sundaram, ME, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 59 (2014), 1375–1385.
48. 48 Sullivan, SG, Kelly, H, Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis 57 (2013), 474–476.
49. 49 Skowronski, DM, Sabaiduc, S, Chambers, C, et al. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Euro Surveill, 21, 2016, 30112.
50. 50 Skowronski, DM, Chambers, C, Sabaiduc, S, et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season. Clin Infect Dis 63 (2016), 21–32.